I find cefepime very useful to diversify empiric antipseudomonal treatments among immunocompromised hosts, and as a carbapenem-sparing agent against ampC producers.
This recent metaanalysis made me wonder if I should stop using it… 🧵(1/5)
@josemolinagb.bsky.social